Gene Name	Entrez ID	Drug Name	Chembl ID	Interaction Types	Sources	publications
FOXP3	50943	EPIRUBICIN	CHEMBL417		CIViC	22431701

Gene Name	Variant	Alleles	Chemical	Phenotype Category	Significance	Notes	Sentence	Publications	Annotation ID
FOXP3	rs3761548	G	methotrexate	other	yes	Patients with moderate to severe psoriasis included. Primary endpoint was a decrease in Psoriasis Area Severity Index (PASI) score of 75 (75% decrease in score) after 12 weeks of MTX treatment. Patients with a PASI score above 50 were considered responders while those below were considered non-responders.	Allele G is associated with decreased response to methotrexate in people with Psoriasis as compared to allele T.	28444425	1448616510